Mosaic ImmunoEngineering Inc. (CPMV) stock
CPMVOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.33+0.00 (0.00%)
Close on Oct 19, 2026Market cap $2.41MP/E –Yield –
Mosaic ImmunoEngineering enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Mosaic ImmunoEngineering's enterprise value was $2.41M on Oct 19, 2026, against $6.02M a year earlier. Over the last 5 years it ranged from $434.46K to $400.64M, with a median of $5.50M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $2.41M | +8.6% |
| 2025 | Dec 31, 2025 | $2.22M | -56.2% |
| 2024 | Dec 31, 2024 | $5.07M | +23.9% |
| 2023 | Dec 29, 2023 | $4.09M | -39.7% |
| 2022 | Dec 30, 2022 | $6.78M | -98.3% |
| 2020 | Jun 30, 2020 | $400.64M | +0.1% |
| 2019 | Dec 31, 2019 | $400.15M | -50.0% |
| 2018 | Dec 31, 2018 | $800.75M | -20.0% |
| 2017 | Dec 29, 2017 | $1.00B | +25.1% |
| 2016 | Dec 30, 2016 | $800.09M | -50.0% |
| 2015 | Dec 31, 2015 | $1.60B | -73.4% |
| 2014 | Dec 31, 2014 | $6.01B | -70.3% |
| 2013 | Dec 31, 2013 | $20.26B | – |
See a number that looks wrong?